InspireMD Announces Completion of Enrollment in C-Guardians U.S. Investigational Device Exemption (IDE) Clinical Trial
Trial designed to support potential U.S. marketing approval of the CGuard™ Prime EPS stent system
Source: dicardiology.com
Page 5 - Device Exemption News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Device Exemption. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Device Exemption Today - Breaking & Trending Today
InspireMD Announces Completion of Enrollment in C-Guardians U.S. Investigational Device Exemption (IDE) Clinical Trial
26.06.2023 - Trial designed to support potential U.S. marketing approval of the CGuard Prime EPS stent system Study also included first-in-human cases treated with CGuard Prime CAS stent delivery platform Company anticipates study results and Premarket ... Seite 1
Source: wallstreet-online.de
XVIVO's IDE Application for its Innovative Heart Preservation Technology ... 2023-05-15
XVIVO’s IDE Application for its Innovative Heart Preservation Technology ...
Source: pr-inside.com
Globus Medical Announces FDA Approval for its Non-Fusion Scoliosis Correction System, the Latest Advancement for Young Patients with Idiopathic Scoliosis
REFLECT™ is approved through the FDA’s Humanitarian Device Exemption pathwayAUDUBON, Pa., May 15, 2023 -- Globus Medical, Inc. , a leading musculoskeletal solutions... | May 15, 2023
Source: marketscreener.com
Pulmonx Reports First Quarter 2023 Financial Results
02.05.2023 - REDWOOD CITY, Calif., May 02, 2023 (GLOBE NEWSWIRE) - Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the 'Company'), a global leader in minimally invasive treatments for lung disease, today reported financial results for the first quarter of ...
Source: wallstreet-online.de